Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Interleukin-18 armours antitumour immune effectors.
Journal: Nature reviews. Immunology
Published: June 16, 2026
System-level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated With High One-year Survival and Reduced Cost.
Journal: Transplantation and cellular therapy
Published: March 12, 2026
Addendum: Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase.
Journal: Nature medicine
Published: May 19, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity.
Journal: Cancer cell
Published: April 29, 2025
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.
Journal: The Journal of experimental medicine
Published: April 01, 2025
Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2025
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.
Journal: Blood cancer discovery
Published: March 10, 2025
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.
Journal: Blood cancer discovery
Published: March 10, 2025
Synthetic gene circuits drive disease-fighting T cells.
Journal: Science (New York, N.Y.)
Published: December 05, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 04, 2024
Last Updated: 09/26/2026